The high professional level of our center was confirmed during the sponsor's visit to evaluate the quality of a phase III clinical trial to assess the safety and immunogenicity of the drug GNR-086 conducted at our research center. Thank you for your comments and suggestions, which we will definitely take into account in our future work.
A new visit to the center's opening: a clinical trial to study the efficacy and safety of tosorakimab, compared with placebo, in adult participants with symptomatic COPD in the presence of exacerbations with increased eosinophil levels.
Activities have resumed under the GPL/CT/2023 project – a study of the efficacy and safety of levosalbutamol /ipratropium bromide in patients with mild to moderate asthma.
Our center successfully completed a center qualification visit for a clinical trial to study the efficacy and safety of tosorakimab, compared with placebo, in adult participants with symptomatic COPD in the presence of exacerbations with increased eosinophil levels.
